The Friday 5 from Practical Cardiology is a list composed by the Practical Cardiology editorial staff aimed at highlighting relevant coverage of news in cardiovascular medicine.
Every Friday, Practical Cardiology provides a curated list of 5 articles focused or related to a particular topic. This week, the Friday 5 from Practical Cardiology highlights the top 5 most popular stories from the past week.
A comparison of data from patients with cancer and ASCVD from a nationally representative survey suggests the financial burden of cardiovascular disease was similar to or exceeded the burden imposed by cancer.
A case series of 7 patients from a pair of US medical centers details the treatment and presentation of patients with myocarditis-like illness after receiving a COVID-19 vaccine.
A meta-analysis of 14 studies suggests use of antihypertensive agents known to cross the blood-brain barrier was associated with improved memory recall over time compared to nonpenetrant agents in older adults with hypertension.
New research suggests statin use was associated with significant reductions in risk of cancer among heart failure patients, with this apparent risk reduction becoming greater with prolonged use.
The FDA has granted approval to dabigatran etexilate (Pradaxa) for treatment of blood clots in pediatric patients with VTE and prevention of recurrent blood clots in those who have completed treatment for VTE.